Tumor cells often overexpress indoleamine 2,3-dioxygenase (IDO), which degrades tryptophan via the kynurenine (KP) pathway, promoting immunosuppressive conditions that facilitate tumor progression (43). This evidence concerns the gene IDO2 and neoplasm.